When a baby is born in the United States, a few drops of blood are taken from their heel to test for many conditions that could affect the child’s long-term health or survival. This testing is part of ...

The plasma proteome is a rich source of potential biomarkers for diseases, such as cancer and neurodegenerative disorders. To assess these proteins, scientists commonly draw whole blood samples into ...

WEST LAFAYETTE, Ind. – A device that makes it faster and more convenient to collect and process blood samples has been registered by the U.S. Food and Drug Administration (FDA) as a Class 1 Medical ...

Tasso, maker of at-home blood sample collection systems, is launching the next generation of its devices that aim to support patients enrolled in clinical trials and simplify their participation in ...

The global blood collection devices market is set to grow from USD 9.13 billion in 2025 to USD 13.02 billion by 2030, with a ...

Tasso and InnoVero developed a less-invasive anti-doping blood test being used broadly at the Olympics for the first time.